In this study, we found that AKT3 knockdown or PI3K/AKT signaling inhibition facilitated BC/DTX cell sensitivity to docetaxel, suggesting that AKT3 is important for docetaxel resistance in BC cells. Here, AKT1 is linked to breast cancer.